BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 37175800)

  • 1. Interplay between LncRNAs and microRNAs in Breast Cancer.
    Schwarzenbach H; Gahan PB
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
    Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
    Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
    Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
    Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer.
    Paci P; Colombo T; Farina L
    BMC Syst Biol; 2014 Jul; 8():83. PubMed ID: 25033876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
    Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratification of lncRNA modulation networks in breast cancer.
    Yu WH; Hsu CL; Lin CC; Oyang YJ; Juan HF; Huang HC
    BMC Med Genomics; 2022 May; 14(Suppl 3):300. PubMed ID: 35501896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer.
    Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C
    J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.
    Tuersong T; Li L; Abulaiti Z; Feng S
    Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
    Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.
    Zhang J; Liu L; Li J; Le TD
    Bioinformatics; 2018 Dec; 34(24):4232-4240. PubMed ID: 29955818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation and implications of lncRNAs and miRNAs in oral tongue squamous cell carcinoma: In reply with emphasis on the role of ceRNAs.
    Yang X; Liu L; Shen X; Shi L; Liu W
    Oral Oncol; 2023 Jan; 136():106277. PubMed ID: 36508884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
    Zhang K; Li Q; Kang X; Wang Y; Wang S
    Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
    Venkatesh J; Wasson MD; Brown JM; Fernando W; Marcato P
    Cancer Lett; 2021 Jul; 509():81-88. PubMed ID: 33848519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNAs and microRNAs Groups in the Regulation of Expression Level of a Number of Tumor-Associated Genes in Ovarian Cancer.
    Pronina IV; Filippova EA; Brovkina OI; Burdennyy AM; Kazubskaya TP; Kushlinskii DN; Zhordania KI; Karpukhin AV; Loginov VI; Braga EA; Kushlinskii NE
    Bull Exp Biol Med; 2023 Jan; 174(3):354-359. PubMed ID: 36723744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
    An M; Zang X; Wang J; Kang J; Tan X; Fu B
    Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.